{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:53:27Z","timestamp":1792450407596,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-022-06608-y","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T17:02:49Z","timestamp":1654102969000},"page":"565-571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The relationship of endometrial pathologies with endometrial thickness and inflammatory markers in breast cancers using tamoxifen"],"prefix":"10.1007","volume":"307","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-3973","authenticated-orcid":false,"given":"Esma","family":"Sarioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1103-7357","authenticated-orcid":false,"given":"Fisun","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0658-2366","authenticated-orcid":false,"given":"Ay\u015fe Deniz","family":"Ert\u00fcrk Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"issue":"6","key":"6608_CR1","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3322\/caac.20134","volume":"61","author":"C Desantis","year":"2011","unstructured":"Desantis C, Siegel R, Bandi P, Jemal A (2011) Breast cancer statistics. CA Cancer J Clin 61(6):408\u2013418. https:\/\/doi.org\/10.3322\/caac.20134","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"6608_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s1471-4914(02)02282-7","volume":"8","author":"WC Park","year":"2002","unstructured":"Park WC, Jordan VC (2002) Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med 8(2):82\u201388. https:\/\/doi.org\/10.1016\/s1471-4914(02)02282-7","journal-title":"Trends Mol Med"},{"issue":"9869","key":"6608_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies C, Pan H, Godwin J et al (2013) Long-term effects of continuing adjuvant tamoxifen to 10\u00a0years versus stopping at 5\u00a0years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381(9869):805\u2013816. https:\/\/doi.org\/10.1016\/S0140-6736(12)61963-1","journal-title":"Lancet"},{"issue":"7","key":"6608_CR4","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","volume":"86","author":"B Fisher","year":"1994","unstructured":"Fisher B, Costantino JP, Redmond CK, Fisher ER, Wickerham DL, Cronin WM (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the national surgical adjuvant breast and bowel project (NSABP)B-14. J Natl Cancer Inst 86(7):527\u2013537. https:\/\/doi.org\/10.1093\/jnci\/86.7.527","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"6608_CR5","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","volume":"20","author":"DL Wickerham","year":"2002","unstructured":"Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, Runowicz CD (2002) Association of tamoxifen and uterine sarcoma. J Clin Oncol 20(11):2758\u20132760. https:\/\/doi.org\/10.1200\/JCO.2002.20.11.2758","journal-title":"J Clin Oncol"},{"issue":"2","key":"6608_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1046\/j.1469-0705.1995.06020116.x","volume":"6","author":"R Achiron","year":"1995","unstructured":"Achiron R, Lipitz S, Sivan E, Goldenberg M, Horovitz A, Frenkel Y, Mashiach S (1995) Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet Gynecol 6(2):116\u2013120. https:\/\/doi.org\/10.1046\/j.1469-0705.1995.06020116.x","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"2","key":"6608_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1006\/gyno.2000.5859","volume":"78","author":"L Deligdisch","year":"2000","unstructured":"Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F (2000) Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 78(2):181\u2013186. https:\/\/doi.org\/10.1006\/gyno.2000.5859","journal-title":"Gynecol Oncol"},{"issue":"6","key":"6608_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/s0029-7844(98)00561-4","volume":"93","author":"M Franchi","year":"1999","unstructured":"Franchi M, Ghezzi F, Donadello N, Zanaboni F, Beretta P, Bolis P (1999) Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease. Obstet Gynecol 93(6):1004\u20131008. https:\/\/doi.org\/10.1016\/s0029-7844(98)00561-4","journal-title":"Obstet Gynecol"},{"issue":"2","key":"6608_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1006\/gyno.1997.4739","volume":"66","author":"WF Cheng","year":"1997","unstructured":"Cheng WF, Lin HH, Torng PL, Huang SC (1997) Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 66(2):233\u2013237. https:\/\/doi.org\/10.1006\/gyno.1997.4739","journal-title":"Gynecol Oncol"},{"issue":"12","key":"6608_CR10","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/cncr.10587","volume":"94","author":"I Cohen","year":"2002","unstructured":"Cohen I, Azaria R, Shapira J, Yigael D, Tepper R (2002) Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women. Cancer 94(12):3101\u20133106. https:\/\/doi.org\/10.1002\/cncr.10587","journal-title":"Cancer"},{"issue":"1","key":"6608_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","volume":"8","author":"SA Polin","year":"2008","unstructured":"Polin SA, Ascher AM (2008) The effect of tamoxifen on the genital tract. Cancer Imaging 8(1):135\u2013145. https:\/\/doi.org\/10.1102\/1470-7330.2008.0020","journal-title":"Cancer Imaging"},{"issue":"8630","key":"6608_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/s0140-6736(89)91141-0","volume":"333","author":"T Fornander","year":"1989","unstructured":"Fornander T, Cedermark B, Mattsson A, Skoog L, Theve T, Askergren J et al (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 333(8630):117\u2013120. https:\/\/doi.org\/10.1016\/s0140-6736(89)91141-0","journal-title":"Lancet"},{"issue":"3","key":"6608_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.ygyno.2004.06.033","volume":"94","author":"O Markovitch","year":"2004","unstructured":"Markovitch O, Tepper R, Aviram R, Fishman A, Shapira J, Cohen I (2004) The value of sonohysterography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol 94(3):754\u2013759. https:\/\/doi.org\/10.1016\/j.ygyno.2004.06.033","journal-title":"Gynecol Oncol"},{"issue":"1","key":"6608_CR14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10549-019-05448-w","volume":"179","author":"J Jeon","year":"2020","unstructured":"Jeon J, Kim SE, Lee D-Y, Choi D (2020) Factors associated with endometrial pathology during tamoxifen therapy in women with breast cancer: A retrospective analysis of 821 biopsies. Breast Cancer Res Treat 179(1):125\u2013130. https:\/\/doi.org\/10.1007\/s10549-019-05448-w","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"6608_CR15","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jcp.52.4.278","volume":"52","author":"I Cohen","year":"1999","unstructured":"Cohen I, Perel E, Flex D, Tepper R, Altaras MM, Cordoba M et al (1999) Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients. J Clin Pathol 52(4):278\u2013282. https:\/\/doi.org\/10.1136\/jcp.52.4.278","journal-title":"J Clin Pathol"},{"issue":"19","key":"6608_CR16","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/jnci\/91.19.1654","volume":"91","author":"L Bernstein","year":"1999","unstructured":"Bernstein L, Deapen D, Cerhan JR, Schwartz SM, Liff J, McGann-Maloney E et al (1999) Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91(19):1654\u20131662. https:\/\/doi.org\/10.1093\/jnci\/91.19.1654","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"6608_CR17","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/bjs.10899","volume":"105","author":"CA Fleming","year":"2018","unstructured":"Fleming CA, Heneghan HM, O\u2019Brien D, McCartan DP, McDermott EW, Prichard RS (2018) Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. Br J Surg 105(9):1098\u20131106. https:\/\/doi.org\/10.1002\/bjs.10899","journal-title":"Br J Surg"},{"issue":"3","key":"6608_CR18","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2214\/ajr.168.3.9057510","volume":"168","author":"LE Hann","year":"1997","unstructured":"Hann LE, Giess CS, Bach AM, Tao Y, Baum HJ, Barakat RR (1997) Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR Am J Roentgenol 168(3):657\u2013661. https:\/\/doi.org\/10.2214\/ajr.168.3.9057510","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"6608_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/s0090-8258(03)00441-4","volume":"91","author":"MFK Fung","year":"2003","unstructured":"Fung MFK, Reid A, Faught W, Le T, Chenier C, Verma S, Brydon E, Fung KFK (2003) Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Gynecol Oncol 91(1):154\u2013159. https:\/\/doi.org\/10.1016\/s0090-8258(03)00441-4","journal-title":"Gynecol Oncol"},{"issue":"7","key":"6608_CR20","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1200\/JCO.1999.17.7.2050","volume":"17","author":"CD Love","year":"1999","unstructured":"Love CD, Muir BB, Scrimgeour JB, Leonard RC, Dillon P, Dixon JM (1999) Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 17(7):2050\u20132054. https:\/\/doi.org\/10.1200\/JCO.1999.17.7.2050","journal-title":"J Clin Oncol"},{"issue":"6","key":"6608_CR21","first-page":"580","volume":"19","author":"S Oz\u015fener","year":"1998","unstructured":"Oz\u015fener S, Ozaran A, Itil I, Dikmen Y (1998) Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen. Eur J Gynaecol Oncol 19(6):580\u2013583","journal-title":"Eur J Gynaecol Oncol"},{"issue":"20","key":"6608_CR22","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","volume":"18","author":"B Gerber","year":"2000","unstructured":"Gerber B, Krause A, M\u00fcller H, Reimer T, K\u00fclz T, Makovitzky J, Kundt G, Friese K (2000) Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 18(20):3464\u20133470. https:\/\/doi.org\/10.1200\/JCO.2000.18.20.3464","journal-title":"J Clin Oncol"},{"issue":"4","key":"6608_CR23","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3349\/ymj.2020.61.4.317","volume":"61","author":"M Lee","year":"2020","unstructured":"Lee M, Piao J, Jeon MJ (2020) Risk factors associated with endometrial pathology in premenopausal breast cancer patients treated with tamoxifen. Yonsei Med J 61(4):317\u2013322. https:\/\/doi.org\/10.3349\/ymj.2020.61.4.317","journal-title":"Yonsei Med J"},{"issue":"3","key":"6608_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.maturitas.2005.12.003","volume":"54","author":"P McGurgan","year":"2006","unstructured":"McGurgan P, Taylor LJ, Duff SR, O\u2019Donovan PJ (2006) Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre and post-menopausal women. Maturitas 54(3):277\u2013284. https:\/\/doi.org\/10.1016\/j.maturitas.2005.12.003","journal-title":"Maturitas"},{"key":"6608_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06380-5","author":"LK Nees","year":"2022","unstructured":"Nees LK, Heublein S, Steinmacher S, Juhasz-B\u00f6ss I, Brucker S, Tempfer CB, Wallwiener M (2022) Endometrial hyperplasia as a risk factor of endometrial cancer. Arch Gynecol Obstet. https:\/\/doi.org\/10.1007\/s00404-021-06380-5","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"6608_CR26","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3390\/cancers12092535","volume":"12","author":"G Emons","year":"2020","unstructured":"Emons G, Mustea A, Tempfer C (2020) Tamoxifen and endometrial cancer: a janus-headed drug. Cancers (Basel) 12(9):2535. https:\/\/doi.org\/10.3390\/cancers12092535","journal-title":"Cancers (Basel)"},{"issue":"6","key":"6608_CR27","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00404-020-05559-6","volume":"301","author":"Y Ye","year":"2020","unstructured":"Ye Y, Wang X, Jeschke U, von Sch\u00f6nfeldt V (2020) COX-2-PGE2-EPs in gynecological cancers. Arch Gynecol Obstet 301(6):1365\u20131375. https:\/\/doi.org\/10.1007\/s00404-020-05559-6","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"6608_CR28","doi-asserted-by":"publisher","first-page":"16027","DOI":"10.18632\/oncotarget.13784","volume":"8","author":"L Hu","year":"2017","unstructured":"Hu L, Li M, Ding Y, Pu L, Liu J, Xie J, Cabanero M, Li J, Xiang R, Xiong S (2017) Prognostic value of in cancers: a systematic review and meta-analysis. Oncotarget 8(9):16027\u201316035. https:\/\/doi.org\/10.18632\/oncotarget.13784","journal-title":"Oncotarget"},{"issue":"6","key":"6608_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/clinchem\/43.6.1072","volume":"43","author":"JC Osselaer","year":"1997","unstructured":"Osselaer JC, Jamart J, Scheiff JM (1997) Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem 43(6):1072\u20131076","journal-title":"Clin Chem"},{"issue":"2","key":"6608_CR30","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/CBM-181267","volume":"23","author":"Y Huang","year":"2018","unstructured":"Huang Y, Cui MM, Huang YX, Fu S, Zhang X, Guo H, Wang RT (2018) Preoperative platelet distribution width predicts breast cancer survival. Cancer Biomark 23(2):205\u2013211. https:\/\/doi.org\/10.3233\/CBM-181267","journal-title":"Cancer Biomark"},{"issue":"1","key":"6608_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12876-017-0685-7","volume":"17","author":"S Cheng","year":"2017","unstructured":"Cheng S, Han F, Wang Y, Xu Y, Qu T, Ju Y, Zhiming Lu (2017) The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. BMC Gastroenterol 17(1):163. https:\/\/doi.org\/10.1186\/s12876-017-0685-7","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"6608_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12967-018-1636-y","volume":"16","author":"W Wen","year":"2018","unstructured":"Wen W, Wu P, Li J, Wang H, Sun J, Chen H (2018) Predictive values of the selected inflammatory index in elderly patients with papillary thyroid cancer. J Transl Med 16(1):261. https:\/\/doi.org\/10.1186\/s12967-018-1636-y","journal-title":"J Transl Med"},{"issue":"13","key":"6608_CR33","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.7314\/apjcp.2015.16.13.5397","volume":"16","author":"E Kurtoglu","year":"2015","unstructured":"Kurtoglu E, Kokcu A, Celik H, Sari S, Tosun M (2015) Platelet indices may be useful in discrimination of benign and malign endometrial lesions, and early and advanced stage endometrial cancer. Asian Pac J Cancer Prev 16(13):5397\u20135400. https:\/\/doi.org\/10.7314\/apjcp.2015.16.13.5397","journal-title":"Asian Pac J Cancer Prev"},{"key":"6608_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017818","volume":"98","author":"J Song","year":"2019","unstructured":"Song J, Lai X, Zhang Y, Zheng X, Su J (2019) Preoperative platelet morphology parameters as prognostic predictors for endometrial malignant carcinoma stage and progesterone receptor. Medicine (Baltimore) 98:e17818. https:\/\/doi.org\/10.1097\/MD.0000000000017818","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"6608_CR35","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.7314\/apjcp.2015.16.12.4905","volume":"16","author":"A Karateke","year":"2015","unstructured":"Karateke A, Kaplanoglu M, Baloglu A (2015) Relations of platelet indices with endometrial hyperplasia and endometrial cancer. Asian Pac J Cancer Prev 16(12):4905\u20134908. https:\/\/doi.org\/10.7314\/apjcp.2015.16.12.4905","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-022-06608-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-022-06608-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T15:06:31Z","timestamp":1680707191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-022-06608-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["6608"],"URL":"https:\/\/doi.org\/10.1007\/s00404-022-06608-y","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"18 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interests\u00a0that are directly or indirectly related to the research including the following: research grants from funding agencies; honoraria for speaking at symposia; financial support for attending symposia; financial support for educational programs; employment or consultation; support from a project sponsor; position on advisory board or board of directors or other type of management relationships; multiple affiliations; financial relationships, for example equity ownership or investment interest; intellectual property rights (e.g., patents, copyrights and royalties from such rights); holdings of spouse and\/or children that may have financial interest in the work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study. The ethical approval of the study was obtained from the ethics committee of Haydarpa\u015fa Numune Training and Research Hospital(HNEAH-KAEK 2021\/KK\/14).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}